Catecholamine-Synthesizing Enzymes in Carcinoid Tumors and Pheochromocytomas
Author(s) -
Wim G. Meijer,
Sjef Copray,
Harry Hollema,
Ido P. Kema,
Nynke Zwart,
Ietje Mantingh-Otter,
Thera P. Links,
Pax H.B. Willemse,
Elisabeth G.E. de Vries
Publication year - 2003
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/49.4.586
Subject(s) - pheochromocytoma , endocrinology , medicine , tyrosine hydroxylase , catecholamine , phenylethanolamine n methyltransferase , tryptophan hydroxylase , carcinoid tumors , biology , phenylethanolamine , serotonin , dopamine , receptor , serotonergic
Serotonin is the principal endocrine product of carcinoid tumors, but simultaneously increased production of catecholamines has been described in these tumors. As it is not clear whether these tumors contain specific enzymes for catecholamine synthesis, we aimed to detect catecholamine-synthesizing enzymes [tyrosine hydroxylase (TH), dopamine-beta-hydroxylase (DBH), and phenylethanolamine-N-methyltransferase (PNMT)] in midgut carcinoid tumors and pheochromocytoma and to correlate enzyme expression to serotonin production as well as catecholamines and metabolites excreted in urine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom